Document is current
Any future updates will be listed below
-
Authors
Gale, R. P. https://orcid.org/0000-0002-9156-1676
Hochhaus, A. https://orcid.org/0000-0003-0626-0834
- License Information
-
More Information
Article History
Received: 17 January 2026
Revised: 23 January 2026
Accepted: 28 January 2026
First Online: 19 February 2026
Competing interests
: RPG is a consultant to Antengene Biotech LLC; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd. AH received research support by Novartis, BMS, Incyte, Pfizer and Enliven Pharma. RPG and AH are Editors-in-Chief of LEUKEMIA .
Free to read: This content has been made available to all.
